Pregabalin Patent Expiration
Pregabalin is Used for treating neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia. It was first introduced by Upjohn Us 2 Llc
Pregabalin Patents
Given below is the list of patents protecting Pregabalin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lyrica Cr |
US10022447 (Pediatric) | Solid pharmaceutical compositions containing pregabalin | May 02, 2027 | Upjohn |
| Lyrica Cr |
US8945620 (Pediatric) | Solid pharmaceutical compositions containing pregabalin | May 02, 2027 | Upjohn |
| Lyrica Cr |
US9144559 (Pediatric) | Solid pharmaceutical compositions containing pregabalin | May 02, 2027 | Upjohn |
| Lyrica Cr | US10022447 | Solid pharmaceutical compositions containing pregabalin | Nov 02, 2026 | Upjohn |
| Lyrica Cr | US8945620 | Solid pharmaceutical compositions containing pregabalin | Nov 02, 2026 | Upjohn |
| Lyrica Cr | US9144559 | Solid pharmaceutical compositions containing pregabalin | Nov 02, 2026 | Upjohn |
| Lyrica |
US6001876 (Pediatric) | Isobutylgaba and its derivatives for the treatment of pain |
Jun 30, 2019
(Expired) | Upjohn |
| Lyrica |
US6197819 (Pediatric) | Gamma amino butyric acid analogs and optical isomers |
Jun 30, 2019
(Expired) | Upjohn |
| Lyrica |
USRE41920 (Pediatric) | Isobutylgaba and its derivatives for the treatment of pain |
Jun 30, 2019
(Expired) | Upjohn |
| Lyrica Cr |
US6197819 (Pediatric) | Gamma amino butyric acid analogs and optical isomers |
Jun 30, 2019
(Expired) | Upjohn |
| Lyrica Cr |
USRE41920 (Pediatric) | Isobutylgaba and its derivatives for the treatment of pain |
Jun 30, 2019
(Expired) | Upjohn |
| Lyrica | US6001876 | Isobutylgaba and its derivatives for the treatment of pain |
Dec 30, 2018
(Expired) | Upjohn |
| Lyrica | US6197819 | Gamma amino butyric acid analogs and optical isomers |
Dec 30, 2018
(Expired) | Upjohn |
| Lyrica | USRE41920 | Isobutylgaba and its derivatives for the treatment of pain |
Dec 30, 2018
(Expired) | Upjohn |
| Lyrica Cr | US6197819 | Gamma amino butyric acid analogs and optical isomers |
Dec 30, 2018
(Expired) | Upjohn |
| Lyrica Cr | USRE41920 | Isobutylgaba and its derivatives for the treatment of pain |
Dec 30, 2018
(Expired) | Upjohn |
| Lyrica | US5563175 | GABA and L-glutamic acid analogs for antiseizure treatment |
Oct 08, 2013
(Expired) | Upjohn |
About Veterinary Pregabalin
Pregabalin is used in drugs marketed by 2 different companies: Orion Corp, Triviumvet.
Other drugs containing Pregabalin are: Bonqat , Liavium ca1 .
Veterinary Pregabalin Patents
Given below is the list of patents protecting Pregabalin, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| Bonqat | US12558331 | ORION CORP. | |
Pregabalin's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Pregabalin:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
